A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity DisorderQueensland Brain Institute, University of Queensland, Brisbane Queensland, Australia; School of Environmental and Rural Science, University of New England, Armidale NSW, Australia; Centre for Population Health Research, School of Health Sciences and Sansom Institute of Health Research, University of South Australia, Adelaide, Australia.
Stanley Center for Psychiatric Research, Broad Institute, Cambridge Massachusetts, United States; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston Massachusetts, United States.
Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, Stockholm, Sweden.
23andMe Inc., Mountain View California, United States.
Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde, Denmark; Institute of Biological Psychiatry, MHC Sct. Hans, Mental Health Services Copenhagen, Roskilde, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde, Denmark; Centre for Integrative Sequencing [iSEQ], Aarhus University, Aarhus, Roskilde, Denmark; National Centre for Register-Based Research, Aarhus University, Aarhus, Roskilde, Denmark; Centre for Integrated Register-Based Research, Aarhus University, Aarhus, Roskilde, Denmark.
Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde, Denmark; National Centre for Register-Based Research, Aarhus University, Aarhus, Roskilde, Denmark; Centre for Integrated Register-Based Research, Aarhus University, Aarhus, Roskilde, Denmark.
Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde, Denmark; Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark.
Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde, Denmark; Mental Health Services in the Capital Region of Denmark, Mental Health Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.
Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde, Denmark; Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde, Denmark; Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
Queensland Brain Institute, University of Queensland, Brisbane Queensland, Australia.
Departments of Human Genetics and Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, Netherlands.
Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse NY, United States; K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway.
MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom.
Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde, Denmark; Centre for Integrative Sequencing [iSEQ], Aarhus University, Aarhus, Roskilde, Denmark; Department of Biomedicine–Human Genetics, Aarhus University, Aarhus, Roskilde, Denmark.
Stanley Center for Psychiatric Research, Broad Institute, Cambridge Massachusetts, United States; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston Massachusetts, United States.
Show others and affiliations
2018 (English)In: Biological Psychiatry, ISSN 0006-3223, E-ISSN 1873-2402, Vol. 83, no 12, p. 1044-1053Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) shows substantial heritability and is two to seven times more common in male individuals than in female individuals. We examined two putative genetic mechanisms underlying this sex bias: sex-specific heterogeneity and higher burden of risk in female cases.
METHODS: We analyzed genome-wide autosomal common variants from the Psychiatric Genomics Consortium and iPSYCH Project (n = 20,183 cases, n = 35,191 controls) and Swedish population register data (n = 77,905 cases, n = 1,874,637 population controls).
RESULTS: Genetic correlation analyses using two methods suggested near complete sharing of common variant effects across sexes, with r(g) estimates close to 1. Analyses of population data, however, indicated that female individuals with ADHD may be at especially high risk for certain comorbid developmental conditions (i.e., autism spectrum disorder and congenital malformations), potentially indicating some clinical and etiological heterogeneity. Polygenic risk score analysis did not support a higher burden of ADHD common risk variants in female cases (odds ratio [confidence interval] = 1.02 [0.98-1.06], p = .28). In contrast, epidemiological sibling analyses revealed that the siblings of female individuals with ADHD are at higher familial risk for ADHD than the siblings of affected male individuals (odds ratio [confidence interval] = 1.14 [1.11-1.18], p = 1.5E-15).
CONCLUSIONS: Overall, this study supports a greater familial burden of risk in female individuals with ADHD and some clinical and etiological heterogeneity, based on epidemiological analyses. However, molecular genetic analyses suggest that autosomal common variants largely do not explain the sex bias in ADHD prevalence.
Place, publisher, year, edition, pages
Elsevier, 2018. Vol. 83, no 12, p. 1044-1053
Keywords [en]
ADHD, Epidemiology, GWAS, Neurodevelopmental disorders, Polygenic risk score analysis, Sex bias
National Category
Neurology Psychiatry
Identifiers
URN: urn:nbn:se:oru:diva-67268DOI: 10.1016/j.biopsych.2017.11.026ISI: 000433241800013PubMedID: 29325848Scopus ID: 2-s2.0-85040102598OAI: oai:DiVA.org:oru-67268DiVA, id: diva2:1219000
Note
Funding Agencies:
National Human Genome Research Institute of the National Institutes of Health (NIH) R44HG006981
Wellcome Trust 106047
Australian National Health and Medical Research Council 1078901 1087889
Stanley Medical Research Institute
NIH 1R01MH094469 1R01MH107649-01
Lundbeck Foundation R102-A9118 R155-2014-1724
European Research Council 294838
European Community's Horizon 2020 Programme (H2020/2014-2020) 667302
Novo Nordisk Foundation
Aarhus university
Copenhagen university
Merz
Shire
Lundbeck
Rhodes
Arbor
KenPharm
Ironshore
Akili Interactive Labs
CogCubed
Alcobra
VAYA
Sunovion
Genomind
NeuroLifeSciences
Neurovance
Otsuka
McNeil
Janssen
Novartis
Pfizer
Eli Lilly
2018-06-152018-06-152018-09-06Bibliographically approved